Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph R Weichselbaum

Showing results (71-80 of 364) with videos related to

Pageof 37
Sort By:
Journal of Virology|October 29, 2003
Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1Sunil J Advani, Lizette O Durand, Ralph R Weichselbaum, et al.
Health Physics|November 4, 2011
Mg ATP and antioxidants augment the radioprotective effect of surfactant copolymersAlexander P Soneru, Michael A Beckett, Ralph R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?Stanley L Liauw, Ralph R Weichselbaum, Gregory P Zagaja, et al.
Radiation Research|August 17, 2017
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive ResponseJeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, et al.
Free Radical Biology & Medicine|April 17, 2018
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive responseJeffrey S Murley, Jack L Arbiser, Ralph R Weichselbaum, et al.
Oncoimmunology|December 10, 2013
Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cellsHua Liang, Liufu Deng, Byron Burnette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2015
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation TherapyLiufu Deng, Hua Liang, Sherry Fu, et al.
Future Oncology (London, England)|October 12, 2007
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical applicationKerrington D Smith, Michael Y Shao, Mitchell C Posner, et al.
Technology in Cancer Research & Treatment|September 20, 2007
Characterization of the theorectical radiation dose enhancement from nanoparticlesJohn C Roeske, Luis Nunez, Mark Hoggarth, et al.
Theoretical Biology & Medical Modelling|April 15, 2014
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based modelAbhineet Uppal, Sean C Wightman, Sabha Ganai, et al.
Pageof 37

Showing results (71-80 of 364) with videos related to

Sort By:
Pageof 37
Journal of Virology|October 29, 2003
Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1Sunil J Advani, Lizette O Durand, Ralph R Weichselbaum, et al.
Health Physics|November 4, 2011
Mg ATP and antioxidants augment the radioprotective effect of surfactant copolymersAlexander P Soneru, Michael A Beckett, Ralph R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?Stanley L Liauw, Ralph R Weichselbaum, Gregory P Zagaja, et al.
Radiation Research|August 17, 2017
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive ResponseJeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, et al.
Free Radical Biology & Medicine|April 17, 2018
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive responseJeffrey S Murley, Jack L Arbiser, Ralph R Weichselbaum, et al.
Oncoimmunology|December 10, 2013
Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cellsHua Liang, Liufu Deng, Byron Burnette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2015
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation TherapyLiufu Deng, Hua Liang, Sherry Fu, et al.
Future Oncology (London, England)|October 12, 2007
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical applicationKerrington D Smith, Michael Y Shao, Mitchell C Posner, et al.
Technology in Cancer Research & Treatment|September 20, 2007
Characterization of the theorectical radiation dose enhancement from nanoparticlesJohn C Roeske, Luis Nunez, Mark Hoggarth, et al.
Theoretical Biology & Medical Modelling|April 15, 2014
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based modelAbhineet Uppal, Sean C Wightman, Sabha Ganai, et al.
Pageof 37